• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同基因肿瘤细胞和可溶性膜蛋白对T细胞功能不同途径的刺激。

Stimulation of different pathways of T-cell functions by syngeneic tumor cells and soluble membrane proteins.

作者信息

Bertschmann M, Lüscher E F

出版信息

Cell Immunol. 1983 May;78(1):13-22. doi: 10.1016/0008-8749(83)90255-1.

DOI:10.1016/0008-8749(83)90255-1
PMID:6602000
Abstract

Cells from the draining lymph nodes of DBA/2 mice bearing syngeneic intradermal P-815 tumors represent an excellent responding cell population for secondary stimulation in vitro, despite the virtual absence of response by spleen cells of the same animals. Cytotoxicity is a result of stimulation with intact mitomycin-treated tumor cells. Isolated tumor cell membranes, in the form of small vesicles, stimulated cytotoxicity to a very limited extent and inhibited the development of cytotoxic T lymphocytes over a wide range of concentrations. Membrane proteins solubilized with deoxycholate and papain had only a suppressive effect. Soluble proteins exerted their effect during the induction of cytotoxic T lymphocytes and were ineffective when present during the effector phase of cytotoxic T lymphocytes. The suppressive capacity was shown to reside in a cell population which was sensitive to treatment with monoclonal Lyt-2.1 antibody and complement but not with Lyt-1.1 antibody. This phenotype was compatible with a specific rather than a promiscuous type of suppressor effector cell.

摘要

携带同基因皮内P - 815肿瘤的DBA/2小鼠引流淋巴结中的细胞,是体外二次刺激的优良反应细胞群体,尽管相同动物的脾细胞几乎没有反应。细胞毒性是完整的丝裂霉素处理的肿瘤细胞刺激的结果。以小泡形式存在的分离肿瘤细胞膜在非常有限的程度上刺激细胞毒性,并在很宽的浓度范围内抑制细胞毒性T淋巴细胞的发育。用脱氧胆酸盐和木瓜蛋白酶溶解的膜蛋白只有抑制作用。可溶性蛋白在细胞毒性T淋巴细胞诱导过程中发挥作用,而在细胞毒性T淋巴细胞效应期存在时则无效。抑制能力显示存在于对单克隆Lyt - 2.1抗体和补体治疗敏感但对Lyt - 1.1抗体不敏感的细胞群体中。这种表型与特异性而非混杂型抑制效应细胞相符。

相似文献

1
Stimulation of different pathways of T-cell functions by syngeneic tumor cells and soluble membrane proteins.同基因肿瘤细胞和可溶性膜蛋白对T细胞功能不同途径的刺激。
Cell Immunol. 1983 May;78(1):13-22. doi: 10.1016/0008-8749(83)90255-1.
2
Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.针对小鼠逆转录病毒诱导的同基因T细胞白血病,会产生不同的增殖性T细胞克隆型:病毒gp70抗原特异性MT4 +克隆和识别肿瘤特异性细胞表面抗原的Lyt-2 +溶细胞克隆。
J Immunol. 1985 Jul;135(1):703-13.
3
Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC).T细胞介导免疫的诱导与表达研究。十五、非MHC木瓜蛋白酶敏感靶结构和Lyt-2抗原在同种异体和异种凝集素依赖性细胞毒性(LDCC)中的作用。
J Immunol. 1985 Sep;135(3):1616-23.
4
The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.肿瘤特异性Lyt-1⁺2⁻ T细胞在体内清除肿瘤细胞中的作用。I. Lyt-1⁺2⁻ T细胞在实施体内免疫时不一定需要募集宿主的细胞毒性T细胞前体。
J Immunol. 1984 Sep;133(3):1671-6.
5
Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.针对肿瘤相关抗原(TAA)的辅助性T细胞:优先诱导参与抗TAA细胞毒性T淋巴细胞和抗体反应的辅助性T细胞活性。
J Immunol. 1986 Apr 1;136(7):2715-9.
6
Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice.通过从荷瘤小鼠引流淋巴结中的淋巴细胞体外产生的细胞毒性T淋巴细胞在体内对同基因肿瘤进行免疫治疗性清除。
Eur J Immunol. 1991 Jun;21(6):1403-10. doi: 10.1002/eji.1830210612.
7
Recognition of Rous sarcoma virus-induced tumor antigens by cytotoxic T lymphocytes (CTL): studies on specificity of killing by CTL employing H-2 congenic and recombinant mouse tumor cells.细胞毒性T淋巴细胞(CTL)对劳氏肉瘤病毒诱导的肿瘤抗原的识别:利用H-2同源和重组小鼠肿瘤细胞对CTL杀伤特异性的研究。
Cell Immunol. 1987 Apr 1;105(2):340-54. doi: 10.1016/0008-8749(87)90082-7.
8
Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.效应前体T淋巴细胞对进行性同基因小鼠肉瘤反应的表型分析及细胞机制
Cancer Res. 1990 Jul 15;50(14):4371-6.
9
Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.效应T细胞群体在体内的功能活性。II. 同基因抗MoMULV特异性细胞溶解T细胞克隆所表现出的抗肿瘤活性。
J Immunol. 1984 Sep;133(3):1664-70.
10
Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.荷瘤小鼠体内针对肿瘤产生细胞毒性效应细胞的机制。
Cancer Res. 1986 Nov;46(11):5548-52.

引用本文的文献

1
Proliferative patterns of lymphocytes in lymph nodes during tumour development: involvement of T and B cell areas.肿瘤发展过程中淋巴结内淋巴细胞的增殖模式:T细胞区和B细胞区的累及情况
Br J Cancer. 1984 Apr;49(4):477-84. doi: 10.1038/bjc.1984.75.
2
Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells.抑制细胞缺失疗法:使用血卟啉偶联单克隆抗体在体内选择性清除抑制性T细胞,可使动物排斥同基因肿瘤细胞。
Cancer Immunol Immunother. 1988;26(2):125-31. doi: 10.1007/BF00205605.